Sage Journals: Discover world-class research

Retricted access

Research article

First published 2012-9

Delay in generic entry should remain a concern to competition authorities

Paul Csiszár

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Research article

First published 2021-3

Horizontal Shareholdings and Paragraph IV Generic Entry in the U.S. Pharmaceutical Industry

Jin Xie

The Antitrust Bulletin

Retricted access

Research article

First published 2018-6

The Role of Risk Aversion in Reverse Payment Agreements

Wenqing Li

The Antitrust Bulletin

Retricted access

Research article

First published 2024-08

The Localization of Drug Patent Linkage System in China: Where Should It Go?

Heng Hu, Guoyue Hou

Biotechnology Law Report

Retricted access

Research article

First published 2013-3

Taking Antitrust to Patent School: The Instance of Pay-For-Delay Settlements

Rudolph J.R. Peritz

The Antitrust Bulletin

Retricted access

Research article

First published 2018-7

Pay for Delay Agreements: Antitrust Watch Intensifies

Twinkle Chawla, Ruchi Verma

Journal of National Law University Delhi

Retricted access

Research article

First published 2012-6

Sanofi-Aventis et al. v. Apotex Inc. et al. : The one hundred eight million dollar question

Frederick H Rein, Joseph B Crystal

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Other

First published 2004-1

Secrets of Successful Patent (Non)Litigation

Thomas M. Saunders, Brian L. Michaelis

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Research article

First published 2018-4

Trade,investment and the global economy: Are we entering a new era for health?

Ronald Labonté, Arne Ruckert, Ashley Schram

Global Social Policy

Search results